The role of necroptosis, an alternative form of cell death, in cancer therapy

Expert Review of Anticancer Therapy

Volumn 13, Issue 7, 2013, Pages 883-893

  Yu, Xinfang ^a   Deng, Qipan ^a,b   Bode, Ann M ^b   Dong, Zigang ^b   Cao, Ya ^a,c  

^a Central South University   (China)

^b UNIVERSITY OF MINNESOTA   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

apoptosis; cancer; necroptosis; programmed cell death; receptor interacting protein

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTHRACYCLINE DERIVATIVE; CASPASE; CELL PROTEIN; FAS ANTIGEN; FINGOLIMOD; HIGH MOBILITY GROUP B1 PROTEIN; NECROSTATIN 1; OXALIPLATIN; PROTEIN RIPK1; PROTEIN RIPK2; PROTEIN RIPK3; TRASTUZUMAB; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CELL CULTURE; CANCER THERAPY; CELL STRESS; CORRELATIONAL STUDY; DRUG CYTOTOXICITY; DRUG PROTEIN BINDING; DRUG TARGETING; GENE; GENE FUNCTION; HUMAN; NECROPTOSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; RIP3 GENE; SIGNAL TRANSDUCTION;

EID: 84880797084     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.2013.811180     Document Type: Review

References (99)

1. Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell 147(4), 742-758 (2011
2. Galluzzi L, Vitale I, Abrams JM et al. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 19(1), 107-120 (2012
3. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26(4), 239-257 (1972
4. Mizushima N, Komatsu M. Autophagy: Renovation of cells and tissues. Cell 147(4), 728-741 (2011
5. Mathew R, White E. Autophagy, stress, and cancer metabolism: What doesnt kill you makes you stronger. Cold Spring Harb. Symp. Quant. Biol. 76, 389-396 (2011
6. Eguchi Y, Shimizu S, Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57(10), 1835-1840 (1997
7. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11(10), 700-714 (2010
8. Galluzzi L, Kepp O, Kroemer G. RIP kinases initiate programmed necrosis. J. Mol. Cell Biol. 1(1), 8-10 (2009
9. Li J, McQuade T, Siemer AB et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150(2), 339-350 (2012
10. Degterev A, Huang Z, Boyce M et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1(2), 112-119 (2005
11. Kaczmarek A, Vandenabeele P, Krysko DV. Necroptosis: The release of damage-Associated molecular patterns and its physiological relevance. Immunity 38(2), 209-223 (2013
12. Welz PS, Wullaert A, Vlantis K et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477(7364), 330-334 (2011
13. Bonnet MC, Preukschat D, Welz PS et al. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 35(4), 572-582 (2011
14. Günther C, Martini E, Wittkopf N et al. Caspase-8 regulates TNF-A-induced epithelial necroptosis and terminal ileitis. Nature 477(7364), 335-339 (2011
15. Vercammen D, Beyaert R, Denecker G et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187(9), 1477-1485 (1998
16. Zhang DW, Shao J, Lin J et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325(5938), 332-336 (2009
17. Vanlangenakker N, Bertrand MJ, Bogaert P, Vandenabeele P, Vanden Berghe T. TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis. 2, e230 (2011
18. Ye YC, Yu L, Wang HJ, Tashiro S, Onodera S, Ikejima T. TNFα-induced necroptosis and autophagy via suppression of the p38-NF-κB survival pathway in L929 cells. J. Pharmacol. Sci. 117(3), 160-169 (2011
19. Jouan-Lanhouet S, Arshad MI, Piquet-Pellorce C et al. TRAIL induces necroptosis involving RIPK1/RIPK3-Dependent PARP-1 activation. Cell Death Differ. 19(12), 2003-2014 (2012
20. Thapa RJ, Basagoudanavar SH, Nogusa S et al. NF-κB protects cells from ? interferon-induced RIP1-Dependent necroptosis. Mol. Cell. Biol. 31(14), 2934-2946 (2011
21. Lamkanfi M, Dixit VM. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 8(1), 44-54 (2010
22. He S, Liang Y, Shao F, Wang X. Toll-Like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc. Natl Acad. Sci. USA 108(50), 20054-20059 (2011
23. Robinson N, McComb S, Mulligan R, Dudani R, Krishnan L, Sad S. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat. Immunol. 13(10), 954-962 (2012
24. Radin JN, González-Rivera C, Ivie SE, McClain MS, Cover TL. Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells. Infect. Immun. 79(7), 2535-2543 (2011
25. Festjens N, Vanden Berghe T, Vandenabeele P. Necrosis, a well-orchestrated form of cell demise: Signalling cascades, important mediators and concomitant immune response. Biochim. Biophys. Acta 1757(9-10), 1371-1387 (2006
26. Cho YS, Challa S, Moquin D et al. Phosphorylation-Driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137(6), 1112-1123 (2009
27. Fliss PM, Brune W. Prevention of cellular suicide by cytomegaloviruses. Viruses 4(10), 1928-1949 (2012
28. Upton JW, Kaiser WJ, Mocarski ES. Virus inhibition of RIP3-Dependent necrosis. Cell Host Microbe 7(4), 302-313 (2010
29. Upton JW, Kaiser WJ, Mocarski ES. DAI/ ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11(3), 290-297 (2012
30. Peri P, Nuutila K, Vuorinen T, Saukko P, Hukkanen V. Cathepsins are involved in virus-induced cell death in ICP4 and Us3 deletion mutant herpes simplex virus type 1-infected monocytic cells. J. Gen. Virol. 92(Pt 1), 173-180 (2011
31. Wu YT, Tan HL, Huang Q, Sun XJ, Zhu X, Shen HM. zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFα mediated by the PKC-MAPKs-AP-1 pathway. Cell Death Differ. 18(1), 26-37 (2011
32. Christofferson DE, Li Y, Hitomi J et al. A novel role for RIP1 kinase in mediating TNFα production. Cell Death Dis. 3, e320 (2012
33. Chang L, Kamata H, Solinas G et al. The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FLIP(L) turnover. Cell 124(3), 601-613 (2006
34. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114(2), 181-190 (2003
35. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22(2), 245-257 (2006
36. Fan Y, Yu Y, Shi Y et al. Lysine 63-Linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor α-And interleukin-1β-induced IKK/NF-κB and JNK/AP-1 activation. J. Biol. Chem. 285(8), 5347-5360 (2010
37. Bertrand MJ, Milutinovic S, Dickson KM et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30(6), 689-700 (2008
38. Wertz IE, ORourke KM, Zhou H et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430(7000), 694-699 (2004
39. Christofferson DE, Yuan J. Necroptosis as an alternative form of programmed cell death. Curr. Opin. Cell Biol. 22(2), 263-268 (2010
40. Hitomi J, Christofferson DE, Ng A et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135(7), 1311-1323 (2008
41. Shembade N, Ma A, Harhaj EW. Inhibition of NF-κB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327(5969), 1135-1139 (2010
42. Kreuzaler P, Watson CJ. Killing a cancer: What are the alternatives? Nat. Rev. Cancer 12(6), 411-424 (2012
43. Wang L, Du F, Wang X. TNF-α induces two distinct caspase-8 activation pathways. Cell 133(4), 693-703 (2008
44. Degterev A, Hitomi J, Germscheid M et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4(5), 313-321 (2008
45. Zheng W, Degterev A, Hsu E, Yuan J, Yuan C. Structure-Activity relationship study of a novel necroptosis inhibitor, necrostatin-7. Bioorg. Med. Chem. Lett. 18(18), 4932-4935 (2008
46. Degterev A, Maki JL, Yuan J. Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ. 20(2), 366 (2013
47. Xie T, Peng W, Liu Y et al. Structural basis of RIP1 inhibition by necrostatins. Structure 21(3), 493-499 (2013
48. ODonnell MA, Perez-Jimenez E, Oberst A et al. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat. Cell Biol. 13(12), 1437-1442 (2011
49. Oberst A, Dillon CP, Weinlich R et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-Dependent necrosis. Nature 471(7338), 363-367 (2011
50. Feoktistova M, Geserick P, Kellert B et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 43(3), 449-463 (2011
51. Tourneur L, Chiocchia G. FADD: A regulator of life and death. Trends Immunol. 31(7), 260-269 (2010
52. Osborn SL, Diehl G, Han SJ et al. Fas-Associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis. Proc. Natl Acad. Sci. USA 107(29), 13034-13039 (2010
53. Meylan E, Tschopp J. The RIP kinases: Crucial integrators of cellular stress. Trends Biochem. Sci. 30(3), 151-159 (2005
54. Narayan N, Lee IH, Borenstein R et al. The NAD-Dependent deacetylase SIRT2 is required for programmed necrosis. Nature 492(7428), 199-204 (2012
55. Duprez L, Bertrand MJ, Vanden Berghe T, Dondelinger Y, Festjens N, Vandenabeele P. Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-Dependent apoptosis. J. Biol. Chem. 287(18), 14863-14872 (2012
56. He S, Wang L, Miao L et al Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α. Cell 137(6), 1100-1111 (2009
57. Sun L, Wang H, Wang Z et al. Mixed lineage kinase domain-Like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148(1-2), 213-227 (2012
58. Zhao J, Jitkaew S, Cai Z et al. Mixed lineage kinase domain-Like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc. Natl Acad. Sci. USA 109(14), 5322-5327 (2012
59. Arduíno DM, Esteves AR, Cortes L et al. Mitochondrial metabolism in Parkinsons disease impairs quality control autophagy by hampering microtubule-Dependent traffic. Hum. Mol. Genet. 21(21), 4680-4702 (2012
60. Kim YS, Morgan MJ, Choksi S, Liu ZG. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol. Cell 26(5), 675-687 (2007
61. Yazdanpanah B, Wiegmann K, Tchikov V et al. Riboflavin kinase couples TNF receptor 1 to NADPH oxidase. Nature 460(7259), 1159-1163 (2009
62. Byun HS, Won M, Park KA et al. Prevention of TNF-induced necrotic cell death by rottlerin through a Nox1 NADPH oxidase. Exp. Mol. Med. 40(2), 186-195 (2008
63. Davis CW, Hawkins BJ, Ramasamy S et al. Nitration of the mitochondrial complex I subunit NDUFB8 elicits RIP1-And RIP3-mediated necrosis. Free Radic. Biol. Med. 48(2), 306-317 (2010
64. Irrinki KM, Mallilankaraman K, Thapa RJ et al. Requirement of FADD, NEMO, and BAX/BAK for aberrant mitochondrial function in tumor necrosis factor α-induced necrosis. Mol. Cell. Biol. 31(18), 3745-3758 (2011
65. Soldani C, Scovassi AI. Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update. Apoptosis 7(4), 321-328 (2002
66. Ha HC, Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl Acad. Sci. USA 96(24), 13978-13982 (1999
67. Baines CP, Kaiser RA, Purcell NH et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434(7033), 658-662 (2005
68. Temkin V, Huang Q, Liu H, Osada H, Pope RM. Inhibition of ADP/ATP exchange in receptor-interacting proteinmediated necrosis. Mol. Cell. Biol. 26(6), 2215-2225 (2006
69. Tesniere A, Schlemmer F, Boige V et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene 29(4), 482-491 (2010
70. Obeid M, Tesniere A, Ghiringhelli F et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13(1), 54-61 (2007
71. Vakkila J, Lotze MT. Inflammation and necrosis promote tumour growth. Nat. Rev. Immunol. 4(8), 641-648 (2004
72. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 140(6), 883-899 (2010
73. Galluzzi L, Kroemer G. Necroptosis: A specialized pathway of programmed necrosis. Cell 135(7), 1161-1163 (2008
74. Gamrekelashvili J, Krüger C, von Wasielewski R et al. Necrotic tumor cell death in vivo impairs tumor-specific immune responses. J. Immunol. 178(3), 1573-1580 (2007
75. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4(10), 757-768 (2004
76. Kasof GM, Prosser JC, Liu D, Lorenzi MV, Gomes BC. The RIP-Like kinase, RIP3, induces apoptosis and NF-κB nuclear translocation and localizes to mitochondria. FEBS Lett. 473(3), 285-291 (2000
77. Yang Y, Hu W, Feng S, Ma J, Wu M. RIP3 β and RIP3 ?, two novel splice variants of receptor-interacting protein 3 (RIP3), downregulate RIP3-induced apoptosis. Biochem. Biophys. Res. Commun. 332(1), 181-187 (2005
78. Liu P, Xu B, Shen W et al Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: Suppression of CYLD gene by LEF1. Leukemia 26(6), 1293-1300 (2012
79. Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fässler R. Cyld inhibits tumor cell proliferation by blocking Bcl-3-Dependent NF-κB signaling. Cell 125(4), 665-677 (2006
80. Alameda JP, Moreno-Maldonado R, Navarro M et al. An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells. Oncogene 29(50), 6522-6532 (2010
81. Huang CY, Kuo WT, Huang YC, Lee TC, Yu LC. Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells. Cell Death Dis. 4, e622 (2013
82. Urtishak KA, Edwards AY, Wang LS et al. Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia. Blood 121(14), 2689-2703 (2013
83. Guido C, Panza S, Santoro M et al. Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene. Cell Cycle 11(15), 2911-2921 (2012
84. Horita H, Frankel AE, Thorburn A. Acute myeloid leukemia-Targeted toxin activates both apoptotic and necroptotic death mechanisms. PLoS ONE 3(12), e3909 (2008
85. Jang MS, Lee SJ, Kang NS, Kim E. Cooperative phosphorylation of FADD by Aur-A and Plk1 in response to taxol triggers both apoptotic and necrotic cell death. Cancer Res. 71(23), 7207-7215 (2011
86. Nehs MA, Lin CI, Kozono DE et al. Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers. Surgery 150(6), 1032-1039 (2011
87. Krysko DV, Vanden Berghe T, D'Herde K, Vandenabeele P. Apoptosis and necrosis: Detection, discrimination and phagocytosis. Methods 44(3), 205-221 (2008
88. de Bruin EC, Medema JP. Apoptosis and non-Apoptotic deaths in cancer development and treatment response. Cancer Treat. Rev. 34(8), 737-749 (2008
89. Hu X, Han W, Li L. Targeting the weak point of cancer by induction of necroptosis. Autophagy 3(5), 490-492 (2007
90. Laukens B, Jennewein C, Schenk B et al. Smac mimetic bypasses apoptosis resistance in FADD-or caspase-8-Deficient cells by priming for tumor necrosis factor a-induced necroptosis. Neoplasia 13(10), 971-979 (2011
91. Vanlangenakker N, Vanden Berghe T, Bogaert P et al. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-Dependent reactive oxygen species production. Cell Death Differ. 18(4), 656-665 (2011
92. Dunai ZA, Imre G, Barna G et al. Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells. PLoS ONE 7(7), e41945 (2012
93. Xuan Y, Hu X. Naturally-occurring shikonin analogues-A class of necroptotic inducers that circumvent cancer drug resistance. Cancer Lett. 274(2), 233-242 (2009
94. Han W, Li L, Qiu S et al. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol. Cancer Ther. 6(5), 1641-1649 (2007
95. Tenev T, Bianchi K, Darding M et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol. Cell 43(3), 432-448 (2011
96. Wang G, Wang JJ, Yang GY et al. Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death. Int. J. Nanomedicine 7, 271-280 (2012
97. Hu J, Liu X, Hughes D et al. Herceptin conjugates linked by EDC boost direct tumor cell death via programmed tumor cell necrosis. PloS ONE 6(8), e23270 (2011
98. Vanden Berghe T, Grootjans S, Goossens V et al. Determination of apoptotic and necrotic cell death in vitro and in vivo. Methods doi:10.1016/j.ymeth.2013.02.011 (2013) (Epub ahead of print
99. Saddoughi SA, Gencer S, Peterson YK et al. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-Dependent necroptosis. EMBO Mol. Med. 5(1), 105-121 (2013